Maria Alicia Carrillo Sepulveda specializes in vasculo-metabolic physiology. Dr. Sepulveda received her B.S from the University State of Campinas (UNICAMP, Brazil), and her Specialization in Cardiology from the Heart Institute at the University of Sao Paulo (Brazil). After 4 years in clinical practice, Sepulveda transitioned to a scientific career and received her Ph.D from the University of Sao Paulo (Brazil) where she investigated the mechanisms by which thyroid hormones regulates vascular function. Sepulveda obtained a total of 5 years post-doctoral training in hypertension from Roy J. and Lucille A. Carver College of Medicine at the University of Iowa (USA) and in vascular physiology from the Medical College of Georgia (USA), where she developed an expertise in vascular physiology and pharmacology. While transitioning to Assistant Professor at NYITCOM, Dr. Sepulveda established an independent research program in vascular physiology and metabolism. Sepulveda’s lab focuses on understanding mechanisms by which metabolic disorders such as obesity and diabetes alter key molecular mediators that are essential for maintaining vascular integrity. Sepulveda’s group has recently identified that lysine acetylation, a posttranslational modification (PTM), is linked to metabolic disorder-induced vascular dysfunction. Sepulveda’s laboratory uses cutting-edge integrative approaches (in vitro, ex vivo and in vivo) and state-of-the-art approaches including pre-clinical mouse models of obesity and diabetes, and genetically engineering mutant mice.